Real-Time Collaboration: The Missing Link to Reducing Delays in Clinical Trials

Bringing groundbreaking new therapies from idea to drugstore is no easy feat, and it is not cheap, either. A 2016 study published in the journal Clinical Trials found that the average cost of a Phase 3 trial ranged from US $11.5 million to US $52.9 million.  The opportunity cost of delay in clinical trials can […]